Clinical manifestations and outcomes of West Nile virus infection.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 3939474)

Published in Viruses on February 06, 2014

Authors

James J Sejvar1

Author Affiliations

1: National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. zea3@cdc.gov.

Articles citing this

Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med (2015) 1.74

A High-Performance Multiplex Immunoassay for Serodiagnosis of Flavivirus-Associated Neurological Diseases in Horses. Biomed Res Int (2015) 0.99

West Nile Virus Infection in the Central Nervous System. F1000Res (2016) 0.88

Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proc Natl Acad Sci U S A (2015) 0.87

West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis (2014) 0.86

Arsenite-induced stress granule formation is inhibited by elevated levels of reduced glutathione in West Nile virus-infected cells. PLoS Pathog (2017) 0.80

Induction of virus-specific effector immune cell response limits virus replication and severe disease in mice infected with non-lethal West Nile virus Eg101 strain. J Neuroinflammation (2015) 0.79

A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. PLoS One (2016) 0.76

Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs. Front Microbiol (2016) 0.76

Major emerging vector-borne zoonotic diseases of public health importance in Canada. Emerg Microbes Infect (2015) 0.75

Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile virus Infection. Curr Trop Med Rep (2015) 0.75

No evidence of West Nile virus infection among Polish patients with encephalitis. Cent Eur J Immunol (2017) 0.75

Acute Flaccid Paralysis: The New, The Old, and The Preventable. Open Forum Infect Dis (2015) 0.75

Full-Genome Sequence of a Neuroinvasive West Nile Virus Lineage 2 Strain from a Fatal Horse Infection in South Africa. Genome Announc (2016) 0.75

Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease? Case Rep Rheumatol (2016) 0.75

Emerging arboviruses and public health challenges in Brazil. Rev Saude Publica (2016) 0.75

Extinction of West Nile virus by Favipiravir through lethal mutagenesis. Antimicrob Agents Chemother (2017) 0.75

Articles cited by this

(truncated to the top 100)

The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48

West Nile virus. Lancet Infect Dis (2002) 7.97

West Nile encephalitis epidemic in southeastern Romania. Lancet (1998) 7.73

Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet (2001) 6.49

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med (2005) 5.09

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol (2003) 4.87

Neurologic manifestations and outcome of West Nile virus infection. JAMA (2003) 4.61

A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med (2002) 3.87

West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med (2006) 3.68

West Nile virus: where are we now? Lancet Infect Dis (2004) 3.49

Persistent infection with West Nile virus years after initial infection. J Infect Dis (2010) 3.33

West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03

The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis (2004) 2.86

Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med (2004) 2.49

West Nile virus neuroinvasive disease. Ann Neurol (2006) 2.42

Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis (2003) 2.34

Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis (2001) 2.34

West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis (2006) 2.30

The pathology of human West Nile Virus infection. Hum Pathol (2000) 2.14

Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation (2004) 2.11

Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect (2006) 2.06

Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis (2004) 2.06

Calgary experience with West Nile virus neurological syndrome during the late summer of 2003. Can J Neurol Sci (2004) 1.95

West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis (2010) 1.88

Poliomyelitis due to West Nile virus. N Engl J Med (2002) 1.86

West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84

Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. J Infect Dis (2006) 1.84

West Nile virus infection: a new acute paralytic illness. Neurology (2003) 1.78

The long-term outcomes of human West Nile virus infection. Clin Infect Dis (2007) 1.77

Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med (2004) 1.76

Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol (2003) 1.72

Punctate exanthem of West Nile Virus infection: report of 3 cases. J Am Acad Dermatol (2004) 1.65

West Nile virus-associated flaccid paralysis. Emerg Infect Dis (2005) 1.64

Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis (2003) 1.61

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother (2004) 1.60

Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis (2001) 1.56

Acute anterior radiculitis associated with West Nile virus infection. J Neurol Neurosurg Psychiatry (2003) 1.55

Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis (2006) 1.49

CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology (2005) 1.45

Spectrum of clinical manifestations of West Nile virus infection in children. Pediatrics (2004) 1.45

West Nile virus infection: a pediatric perspective. Pediatrics (2004) 1.45

Neurological manifestations of West Nile virus infection. Can J Neurol Sci (2004) 1.43

West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis (2006) 1.35

Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis (2007) 1.33

West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol (2005) 1.32

Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology (2004) 1.29

Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis (2006) 1.29

The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. Am J Clin Pathol (2003) 1.28

Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol (2004) 1.26

West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol (2005) 1.23

Guillain-Barré syndrome: An unusual presentation of West Nile virus infection. Neurology (2000) 1.19

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet (2003) 1.19

Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis (2003) 1.13

Severe West Nile virus disease in healthy adults. Clin Infect Dis (2003) 1.12

A seroprevalence study of west nile virus infection in solid organ transplant recipients. Am J Transplant (2004) 1.09

Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection. Clin Infect Dis (2003) 1.08

Prognosis after West Nile virus infection. Ann Intern Med (2008) 1.06

Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol (2008) 1.06

Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci (2004) 1.04

West Nile virus and "poliomyelitis". Neurology (2004) 1.04

Transient parkinsonism in West Nile virus encephalitis. Am J Med (2003) 1.03

West Nile virus disease in children, United States, 1999-2007. Pediatrics (2009) 1.02

Findings of long-term depression up to 8 years post infection from West Nile virus. J Clin Psychol (2012) 1.01

Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am J Trop Med Hyg (2010) 1.00

Persistent neuropsychological impairment associated with West Nile virus infection. J Clin Exp Neuropsychol (2010) 1.00

Recovery and prognosticators of paralysis in West Nile virus infection. J Neurol Sci (2005) 1.00

Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve (2003) 0.99

Acute pancreatitis in West Nile Fever. Am J Trop Med Hyg (1974) 0.98

Outcome of West Nile fever in older adults. J Am Geriatr Soc (2002) 0.97

Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. Vector Borne Zoonotic Dis (2010) 0.97

Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis (2012) 0.96

West nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol (2003) 0.95

Plasma cell pleocytosis in cerebrospinal fluid in patients with West Nile virus encephalitis. Clin Infect Dis (2003) 0.94

Delayed-onset and recurrent limb weakness associated with West Nile virus infection. J Neurovirol (2010) 0.93

Depression after infection with West Nile virus. Emerg Infect Dis (2007) 0.93

Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. Antimicrob Agents Chemother (2010) 0.92

Mental status after West Nile virus infection. Emerg Infect Dis (2006) 0.92

West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature. Transpl Infect Dis (2011) 0.88

Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol (2003) 0.88

Evaluation for West Nile Virus (WNV) RNA in urine of patients within 5 months of WNV infection. J Infect Dis (2012) 0.88

Chorioretinal lesions in nonfatal cases of West Nile virus infection. Ophthalmology (2003) 0.88

Arthropod-borne viral infections in children in Vellore, South India, with particular reference to dengue and West Nile viruses. Indian Pediatr (1968) 0.87

Neuropathological findings in West Nile virus encephalitis: a case report. Ann Neurol (2003) 0.87

Multifocal choroiditis associated with West Nile virus encephalitis. Retina (2003) 0.86

West Nile virus chorioretinitis. Br J Ophthalmol (2004) 0.86

West Nile virus infection presenting as cerebellar ataxia and fever: case report. South Med J (2003) 0.85

West Nile virus chorioretinitis. Retina (2003) 0.85

Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients. J Am Board Fam Pract (2004) 0.84

Skin manifestations of West Nile virus infection. Dermatology (2005) 0.84

Electrodiagnostic features of acute paralytic poliomyelitis associated with West Nile virus infection. Muscle Nerve (2004) 0.83

Risk factors for encephalitis from West Nile Virus: a matched case-control study using hospitalized controls. Zoonoses Public Health (2009) 0.83

Seroprevalence of West Nile virus infection in solid organ transplant recipients. Transpl Infect Dis (2009) 0.83

West Nile encephalitis presenting as a stroke. Ann Emerg Med (2003) 0.83

Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1. Antiviral Res (2011) 0.83

Ocular manifestations of West Nile virus. Curr Opin Ophthalmol (2004) 0.82

An investigation of depression and fatigue post West Nile virus infection. S D Med (2010) 0.81

Electroencephalography findings in adult patients with West Nile virus-associated meningitis and meningoencephalitis. Clin Infect Dis (2003) 0.81

West Nile virus infection in the pediatric population. Pediatr Infect Dis J (2006) 0.80

Characteristics of the rash associated with West Nile virus fever. Clin Infect Dis (2005) 0.80

West Nile meningo-encephalitis infection in a kidney transplant recipient. Transplant Proc (2003) 0.80